Akeso, a pharmaceutical company whose self-developed new drug outperformed the global anti-cancer "drug king", was established in 2012 at the National Health Science and Technology Industrial Base within Zhongshan Torch High-Tech Zone. It is a leading Chinese bispecific antibody enterprise, nurtured and developed right here in Zhongshan, with global competitiveness. 

The biomedical and health industry is one of the four leading sectors in Zhongshan's new "Top Ten Flagship Clusters" of modern industries. Thanks to Zhongshan's pioneering spirit of innovation and entrepreneurship, this small city has nurtured a leading enterprise that has stepped onto the world stage.